Source comparison
Comparison: TB-500 vs Other Regenerative Peptides and Thyroid Impact
TB-500 (Thymosin Beta-4) Actin-binding, angiogenesis, immune modulation Moderate. Amino acid metabolism and ATP synthesis +0.3 to +0.8 mIU/L in high-dose protocols Sustained elevation during healing phases Reveals subclinical insufficiency but doesn't suppress
This comparison does not assign a generated winner or score.
- TB-500 (Thymosin Beta-4)
- Actin-binding, angiogenesis, immune modulation
- Moderate. Amino acid metabolism and ATP synthesis
- +0.3 to +0.8 mIU/L in high-dose protocols
- Sustained elevation during healing phases
- Reveals subclinical insufficiency but doesn't suppress thyroid function directly
- BPC-157
- Gastric pentadecapeptide, vascular repair, NO pathway modulation
- Low. Minimal amino acid load, shorter peptide chain
- +0.1 to +0.3 mIU/L in standard protocols
- Transient increase during active injury repair
- Thyroid impact negligible in most research models
- GHK-Cu
- Copper peptide, collagen stimulation, anti-inflammatory signaling
- Low-moderate. Copper metabolism intersects with thyroid peroxidase function
- +0.2 to +0.5 mIU/L if baseline copper is marginal
- Moderate. Copper availability affects thyroid enzyme activity
- Copper status matters more than peptide dose
- Epitalon
- Pineal peptide, telomerase activation, circadian regulation
- Variable. Affects melatonin-thyroid axis indirectly
- +0.4 to +1.2 mIU/L in protocols longer than 10 days
- Circadian disruption can alter TSH pulsatility
- Thyroid shifts correlate with melatonin receptor density
- TB-500 sits in the middle tier for thyroid metabolic demand. Higher than BPC-157 or GHK-Cu but lower than growth hormone secretagogues or high-dose IGF-1 protocols. The key distinction is that TB-500's thyroid impact is proportional to the intensity of tissue repair activity it's supporting. A researcher using TB-500 for chronic tendinopathy will see different thyroid marker shifts than someone using it post-surgery during acute wound healing.